跳至主要内容
临床试验/CTRI/2024/03/063582
CTRI/2024/03/063582尚未招募3 期

Randomized controlled trial comparing Octreotide with standard treatment diet restriction versus standard treatment for chyle leak in head and neck cancer patients - NI

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Head and neck cancer patients with neck dissection developing chyle leak in postoperative period as per clinical assessment milky white drain fluid or biochemical analysis
  • -Eastern Cooperation Oncology Group performance status 0 to 2

排除标准

  • -Those patients who are considered unfit for the surgery in view of
  • -Abnormal Renal Liver function
  • -Uncontrolled DM, HTN more than or equal to 140 by 90 mmHg after appropriate medication
  • -Cardiac abnormality- Ischemic heart disease Ejection fraction less than 50 percent
  • -Any past history of gastric or duodenal ulcer
  • -Allergic to Octreotide

研究者

相似试验

Octreotide drug compared with diet Restriction in... | 临床试验